September 15, 2024
12:39 pm
We are delighted to announce that Brad Groves, Associate Director of Managed Access at NICE, has agreed to join us to explain the appraisal process; what this means for the current MAA and to answer questions from the Duchenne community.
The session will also be a chance to learn more about how you can get involved; hear from people involved in the first campaign for access and to discuss your experience of Translarna, which will help Action Duchenne and Muscular Dystrophy UK finalise our joint response to the appraisal consultation.